Literature DB >> 15580733

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).

C B Bridges1, A G Winquist, K Fukuda, N J Cox, J A Singleton, R A Strikas.   

Abstract

This report updates 1999 recommendations by the Advisory Committee on Immunization Practices (ACIP) on the use of influenza vaccine and antiviral agents (MMWR 1999;48[No. RR-4]: 1-29). These recommendations include five principal changes: a) the age for universal vaccination has been lowered to 50 years from 65 years; b) scheduling of large, organized vaccination campaigns after mid-October may be considered because the availability of vaccine in any location cannot be assured consistently in the early fall; c) 2000-2001 trivalent vaccine virus strains are A/Moscow/10/99 (H3N2)-like, A/New Caledonia/20/99 (H1N1)-like, and B/Beijing/184/93-like strains; d) information on neuraminidase-inhibitor antiviral drugs has been added; and e) a list of other influenza-related infection control documents for special populations has been added. This report and other information on influenza can be accessed at the website for the Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, CDC at <http://www. cdc.gov/ncidod/diseases/flu/fluvirus.htm>.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 15580733

Source DB:  PubMed          Journal:  MMWR Recomm Rep        ISSN: 1057-5987


  57 in total

1.  Infections Associated with Health-care Personnel: Vaccine-preventable Diseases and Bloodborne Pathogens.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-12       Impact factor: 3.725

2.  Semmelweis revisited: the ethics of infection prevention among health care workers.

Authors:  E Rea; R Upshur
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

Review 3.  Oseltamivir: a review of its use in influenza.

Authors:  K McClellan; C M Perry
Journal:  Drugs       Date:  2001       Impact factor: 9.546

4.  Racial/ethnic differences in influenza vaccination coverage in high-risk adults.

Authors:  Leonard E Egede; Deyi Zheng
Journal:  Am J Public Health       Date:  2003-12       Impact factor: 9.308

5.  Modeling the spread of annual influenza epidemics in the U.S.: the potential role of air travel.

Authors:  R F Grais; J H Ellis; A Kress; G E Glass
Journal:  Health Care Manag Sci       Date:  2004-05

6.  In vitro anti-influenza virus activities of sulfated polysaccharide fractions from Gracilaria lemaneiformis.

Authors:  Mei-Zhen Chen; Hao-Gui Xie; La-Wei Yang; Zao-Hui Liao; Jie Yu
Journal:  Virol Sin       Date:  2010-10-08       Impact factor: 4.327

7.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

8.  Use of preventive care by the working poor in the United States.

Authors:  Joseph S Ross; Susannah M Bernheim; Elizabeth H Bradley; Hsun-Mei Teng; William T Gallo
Journal:  Prev Med       Date:  2006-12-29       Impact factor: 4.018

Review 9.  Immunosenescence of ageing.

Authors:  A L Gruver; L L Hudson; G D Sempowski
Journal:  J Pathol       Date:  2007-01       Impact factor: 7.996

10.  Influenza vaccination options to prevent hospitalization.

Authors:  Moshe Ipp Frcp; Nancy L Young; Teresa To; Adam Cheng; Fred Lan; Elaine El Wang
Journal:  Paediatr Child Health       Date:  2003-12       Impact factor: 2.253

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.